The rise of GLP-1 weight loss medications has sparked an interesting phenomenon, one that has plastic surgeons on Long Island buzzing. These medications, such as Ozempic, Wegovy, and Zepbound, have become a game-changer for many, but they've also brought about a unique set of challenges.
Jeanne Erland's journey is a perfect example. She successfully lost an impressive 164 pounds over two years with the help of these medications and a dedicated lifestyle change. However, the loose skin that remained was a constant reminder of her past struggles. It hindered her workouts and limited her clothing choices, leading her to consider plastic surgery as the next step in her transformation.
The Plastic Surgery Boom
Plastic surgeons on Long Island are reporting a significant increase in patients seeking procedures after weight loss with GLP-1 medications. This trend is not just limited to cosmetic concerns; many procedures are considered medically necessary. About 20% of individuals taking these medications have already undergone plastic surgery, while a substantial 39% are actively considering it.
Dr. Kevin Kresofsky, a plastic surgeon, describes the skin's inability to "recoil and tighten" after significant weight loss, comparing it to "deflating a balloon." This issue is not limited to the face, as commonly discussed with "Ozempic face," but extends to the abdomen, breasts, thighs, and arms, creating functional and aesthetic challenges.
The Impact on Patients
For patients like Jeanne, the excess skin is more than just a cosmetic issue. It affects their daily lives, from the clothes they can wear to the physical activities they can engage in. Female patients who have experienced weight fluctuations due to pregnancy often face even greater challenges in regaining their pre-pregnancy shape.
Dr. Kevin Small, director of plastic surgery for the New York Bariatric Group, has seen a significant increase in patients losing weight with GLP-1 medications. He explains that the change in a person's center of gravity and the overhanging skin can cause strain on the shoulders and back, impacting their overall health and well-being.
The Science Behind GLP-1 Drugs
GLP-1 drugs, or Glucagon-like peptide-1 receptor agonists, were initially developed to treat diabetes. However, their ability to slow digestion and prolong the feeling of fullness has made them a popular choice for weight loss. The first GLP-1 medicines specifically approved for weight loss hit the market in 2021, and their impact has been significant. A 2025 tracking poll found that one in eight adults is currently taking a GLP-1 drug for weight loss or to manage a chronic condition.
The Need for Lifestyle Changes
While GLP-1 medications can lead to dramatic weight loss, they are not a standalone solution. Dr. David Pincus, a plastic surgeon, emphasizes the importance of lifestyle modifications. He likens healthy bones and muscles to a "scaffold" for the skin, highlighting that GLP-1s alone are not enough. Without changes to diet and exercise habits, the benefits of these medications may be short-lived, and the potential side effects, such as muscle wasting and loss of core strength, could outweigh the initial weight loss gains.
Conclusion
The rise of GLP-1 weight loss medications has undoubtedly transformed the obesity treatment landscape. However, as we've seen with Jeanne's story and the experiences of many others, it's crucial to approach these medications with a comprehensive understanding of their potential benefits and challenges. While they can be a powerful tool in the fight against obesity, they should be used in conjunction with a healthy lifestyle to ensure long-term success and minimize the need for extensive medical interventions down the line.
